[在接受过敏原下方言免疫治疗的患者中,开发和验证一种药物坚持的预测模型]

W J Wan1, Q Xu2, Z J Gu3

  • 1School of Nursing, Nanjing Medical University, Nanjing 211166, China Department of Allergology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China Department of Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.

概括

这项研究开发了一种预测模型,用于在舌下免疫疗法 (SLIT) 患者的药物坚持. 该模型基于信念,焦虑,社会支持和疾病感知,显示了临床干预的良好预测性能.